Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

NCT04149262 · clinicaltrials.gov ↗

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Fast-acting insulin aspart
DRUG: Rapid-acting insulin analogues (insulin aspart or insulin lispro)

Sponsor

Aristotle University Of Thessaloniki